TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer
Name:
36452431.pdf
Size:
2.041Mb
Format:
PDF
Description:
Identified with Open Access button
Authors
Thomson, David JCruickshank, C.
Baines, H.
Banner, R.
Beasley, M.
Betts, G.
Bulbeck, H.
Charlwood, Frances
Christian, J.
Clarke, Matthew
Donnelly, O.
Foran, B.
Gillies, C.
Griffin, C.
Homer, J. J.
Langendijk, J. A.
Lee, Lip W
Lester, J.
Lowe, Matthew
McPartlin, A.
Miles, E.
Nutting, C.
Palaniappan, N.
Prestwich, R.
Price, James M
Roberts, Clare
Roe, J.
Shanmugasundaram, R.
Simões, R.
Thompson, A.
West, C.
Wilson, Lorna
Wolstenholme, J.
Hall, E.
Affiliation
The Christie NHS Foundation Trust, ManchesterIssue Date
2023
Metadata
Show full item recordAbstract
•There is a lack of prospective level I evidence for the use of PBT for most adult cancers including oropharyngeal squamous cell carcinoma (OPSCC).•TORPEdO is the UK's first PBT clinical trial and aims to determine the benefits of PBT for OPSCC.•Training and support has been provided before and during the trial to reduce variations of contouring and radiotherapy planning.•There is a strong translational component within TORPEdO. Imaging and physics data along with blood, tissue collection will inform future studies in refining patient selection for IMPT.Citation
Thomson DJ, Cruickshank C, Baines H, Banner R, Beasley M, Betts G, et al. TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer. Clinical and translational radiation oncology. 2023 Jan;38:147-54. PubMed PMID: 36452431. Pubmed Central PMCID: PMC9702982 personal relationships that could have appeared to influence the work reported in this paper. Epub 2022/12/02. eng.Journal
Clinical and Translational Radiation OncologyDOI
10.1016/j.ctro.2022.11.010PubMed ID
36452431Additional Links
https://dx.doi.org/10.1016/j.ctro.2022.11.010Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.ctro.2022.11.010
Scopus Count
Collections
Related articles
- Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy.
- Authors: Taku N, Wang L, Garden AS, Rosenthal DI, Gunn GB, Morrison WH, Fuller CD, Phan J, Reddy JP, Moreno AC, Spiotto MT, Chronowski G, Shah SJ, Mayo LL, Gross ND, Ferrarotto R, Zhu XR, Zhang X, Frank SJ
- Issue date: 2021 Jun 4
- Hitting the Target: Developing High-quality Evidence for Proton Beam Therapy Through Randomised Controlled Trials.
- Authors: Hudson EM, Slevin F, Biscombe K, Brown SR, Haviland JS, Murray L, Kirby AM, Thomson DJ, Sebag-Montefiore D, Hall E
- Issue date: 2024 Feb
- High-dose Intensity-modulated proton therapy versus Standard-dose Intensity-modulated RadIation therapy for esophageal squamous cell carcinoma (HI-SIRI): study protocol for a randomized controlled clinical trial.
- Authors: Lertbutsayanukul C, Kitpanit S, Kannarunimit D, Chakkabat C, Oonsiri S, Thephamongkhol K, Puataweepong P, Katanyoo K, Sukhaboon J, Tovanabut C, Chongsathientham S, Treeratsapanich P, Soonthornrak J, Prayongrat A
- Issue date: 2022 Oct 22
- TORPEdO - A Phase III Trial of Intensity-modulated Proton Beam Therapy Versus Intensity-modulated Radiotherapy for Multi-toxicity Reduction in Oropharyngeal Cancer.
- Authors: Price J, Hall E, West C, Thomson D
- Issue date: 2020 Feb
- Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus Proton Therapy for Oropharyngeal Squamous Cell Carcinoma.
- Authors: Sher DJ, Tishler RB, Pham NL, Punglia RS
- Issue date: 2018 Jul 15